KEYNOTE-826: Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer Last updated on Apr 21, 2024 Previous Preparation for Board Exams Next GOG 209: Carboplatin and Paclitaxel for Advanced Endometrial Cancer